Topiramate Tablet
Product Images NDC 63187-228

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 63187-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43e1322a-figure-01 (43e1322a Figure 01)

43e1322a-figure-01 (43e1322a Figure 01)
Chemical structure of Topiramate illustrating its molecular arrangement with carbon, oxygen, sulfur, nitrogen, and hydrogen atoms depicted in a ring and chain format.*
FDA Label Image

43e1322a-figure-02 (43e1322a Figure 02)

43e1322a-figure-02 (43e1322a Figure 02)
A line chart showing the cumulative rates for time to first seizure over a period of 500 days for two Topiramate dosages: 50 mg/day and 400 mg/day. The 400 mg/day group exhibits consistently lower cumulative seizure rates compared to the 50 mg/day group, with a noted statistical significance (p = 0.0002).*
FDA Label Image

43e1322a-figure-03 (43e1322a Figure 03)

43e1322a-figure-03 (43e1322a Figure 03)
Image shows multiple round tablets embossed with "278," "279," "280," "281," and "1G" in various font sizes and styles. These embossed numbers and letters typically identify tablet strengths or product codes for Topiramate oral tablets by Proficient Rx LP.*
FDA Label Image

Image 01

Image 01
Topiramate 50 mg tablets label from Proficient Rx LP with NDC 63187-228-30. The label indicates a package of 30 oral tablets, each containing 50 mg of topiramate. It includes dispensing instructions, a description of the tablets as yellow, film-coated, round, biconvex, with specific debossing, and storage conditions of 20°-25°C. Manufacturer information is listed as Ascent Pharmaceuticals, Inc., Central Islip, NY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.